Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma

MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII and HISAHIRO MATSUBARA
Anticancer Research November 2009, 29 (11) 4433-4438;
MASAYUKI KANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m_kano{at}graduate.chiba-u.jp
SHIGERU YAMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ISAMU HOSHINO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO MURAKAMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUNORI AKUTSU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUHITO SAKATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANORI NISHIMORI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIRO USUI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIMASA MIYAZAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADASHI KAMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROHIKO TSUJII
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HISAHIRO MATSUBARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 11 4433-4438
PMID 
20032389

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 25, 2009
  • Revision received August 14, 2009
  • Accepted September 1, 2009
  • Published online December 23, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MASAYUKI KANO1,
  2. SHIGERU YAMADA2,
  3. ISAMU HOSHINO1,
  4. KENTARO MURAKAMI1,
  5. YASUNORI AKUTSU1,
  6. HARUHITO SAKATA1,
  7. TAKANORI NISHIMORI1,
  8. AKIHIRO USUI1,
  9. YUKIMASA MIYAZAWA1,
  10. TADASHI KAMADA2,
  11. HIROHIKO TSUJII2 and
  12. HISAHIRO MATSUBARA1
  1. 1Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba
  2. 2National Institute of Radiological Science, Chiba, Japan
  1. Correspondence to: Masayuki Kano, Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuoku, Chiba 260-0856, Japan. Tel/Fax +81 432262111, e-mail: m_kano{at}graduate.chiba-u.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 24 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 11
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII, HISAHIRO MATSUBARA
Anticancer Research Nov 2009, 29 (11) 4433-4438;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII, HISAHIRO MATSUBARA
Anticancer Research Nov 2009, 29 (11) 4433-4438;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
  • Google Scholar

More in this TOC Section

  • Gossypol Inhibits GLI3-dependent SHH Signaling to Selectively Target SPOP-deficient Breast Cancer Cells
  • Ubiquitin Ligase RNF149 Promotes Head and Neck Cancer Growth via Downregulation of CDKN2C
  • NK92-exo Induces Ferroptosis in A549 Cells by Targeting a miR-663a-SLC11A2 Axis
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire